These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23391668)

  • 1. Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus.
    Sheikh-Ali M; Raheja P; Borja-Hart N
    Postgrad Med; 2013 Jan; 125(1):17-33. PubMed ID: 23391668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
    Reasner CA
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?
    Beller GA
    J Am Coll Cardiol; 2007 May; 49(19):1918-23. PubMed ID: 17498575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus: practical approaches for primary care physicians.
    Gavin JR; Freeman JS; Shubrook JH; Lavernia F
    J Am Osteopath Assoc; 2011 May; 111(5 Suppl 4):S3-12; quiz S13. PubMed ID: 21697547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.
    Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A
    J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic interventions and success in risk factor control for secondary prevention of stroke.
    Alvarez-Sabin J; Quintana M; Hernandez-Presa MA; Alvarez C; Chaves J; Ribo M
    J Stroke Cerebrovasc Dis; 2009; 18(6):460-5. PubMed ID: 19900649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
    Niswender K
    Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
    Wiersma JJ; Trip MD; Piek JJ
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
    Haffner S
    Am J Cardiol; 2005 Aug; 96(4A):33E-36E. PubMed ID: 16098841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies.
    Bays HE
    Am J Cardiol; 2012 Nov; 110(9 Suppl):4B-12B. PubMed ID: 23062567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective.
    Cubbon R; Kahn M; Kearney MT
    Int J Clin Pract; 2008 Feb; 62(2):287-99. PubMed ID: 18036163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dietary therapy for prevention and treatment of atherosclerosis from the perspective of anti-inflammation].
    Tada N
    Nihon Rinsho; 2011 Jan; 69(1):110-8. PubMed ID: 21226270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus.
    Peng WH; Lu L; Wang LJ; Yan XX; Chen QJ; Zhang Q; Zhang RY; Shen WF
    Arch Med Res; 2009 Jul; 40(5):393-8. PubMed ID: 19766904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.